v3.26.3
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS      
Cash and cash equivalents $ 1,820,365 $ 2,189,232 $ 468,998
Inventory, net 12,807 12,807 13,689
Prepaid expenses and other current assets 76,451 124,779 44,794
TOTAL CURRENT ASSETS 1,909,623 2,326,818 527,481
NON-CURRENT ASSETS      
Intellectual property, net, a related party   2,850,000
Investment in NovoDX, a related party   500,000
TOTAL NON-CURRENT ASSETS   3,350,000
TOTAL ASSETS 1,909,623 2,326,818 3,877,481
CURRENT LIABILITIES      
Accounts payable 293,805 170,351 169,432
Accrued expenses and other current liabilities 90,841 6,493 16,673
TOTAL CURRENT LIABILITIES 384,646 176,844 186,105
NON CURRENT LIABILITIES      
Long-term debt, net 58,650
TOTAL NON CURRENT LIABILITIES 58,650
TOTAL LIABILITIES 384,646 235,494 186,105
COMMITMENTS AND CONTINGENCIES (Note 8)
MEZZANINE EQUITY      
Series A Convertible Redeemable preferred stock, value 4,232,686  
TOTAL MEZZANINE EQUITY 4,232,686  
STOCKHOLDERS’ EQUITY (DEFICIT)      
Preferred stock, value
Common stock, value 9,092 14,762 13,110
Additional paid-in capital 6,963,403 9,135,341 4,541,057
Common stock payable 258,780 83,003
Subscription receivable (800) (800)
Receivable from related party for stock repurchase (150,000)  
Accumulated deficit (9,788,184) (7,140,982) (862,791)
TOTAL STOCKHOLDERS’ EQUITY (DEFICIT) (2,707,709) 2,091,324 3,691,376
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY (DEFICIT) $ 1,909,623 $ 2,326,818 $ 3,877,481